Vaccination against influenza: a five-year study in the Post Office
- PMID: 110876
- PMCID: PMC2130105
- DOI: 10.1017/s0022172400025936
Vaccination against influenza: a five-year study in the Post Office
Abstract
An injection of influenza vaccine was offered to approximately 60 000 Postal and Telecommunications staff at the beginning of five successive winters. The sickness absence of this group, which included those who accepted the offer of vaccine as well as those who did not, was compared throughout the winter with that of a similar number of employees who were not offered vaccine. The two groups, ;vaccinated' and control, comprised the staff of nearly 400 Post Office units scattered throughout Great Britain, the units of the two groups being matched as far as practicable for numbers employed, type of work, region and type of location.The proportion who accepted vaccine fell from 42% in the first year (when only 26 000 Telecommunications employees were offered vaccine) to 35% in the second year, and 25% by the fifth year.With the exception of Telecommunications employees in 1972-73, the sickness absence rate of the group offered vaccine was less than that of the group not offered vaccine, and the difference was evident during the winter observation periods both when influenza was prevalent and when it was not. In the last four years of the study the average difference in sickness absence between the ;vaccinated' and control groups was 1.26 days per 100 employees per week during and 1.12 days outside the influenza periods. Moreover, the difference during the influenza periods was greater than could be expected from the acceptance rate of vaccine and the estimated attack rate of influenza. The apparent reduction in sickness absence of the group offered vaccine in comparison with the group not offered vaccine represented an appreciable saving in cost.It is suggested than an annual influenza vaccination campaign in industry may produce financial benefit, but that only a proportion of the benefit is due to an improvement in health.
Similar articles
-
Influenza vaccination and absenteeism among healthy working adults: a cost-benefit analysis.Ann Ig. 2020 May-Jun;32(3):234-244. doi: 10.7416/ai.2020.2346. Ann Ig. 2020. PMID: 32266361
-
A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.PLoS One. 2018 Jun 7;13(6):e0198685. doi: 10.1371/journal.pone.0198685. eCollection 2018. PLoS One. 2018. PMID: 29879206 Free PMC article.
-
Sickness absence following a campaign of vaccination against influenza in the workplace.Occup Med (Lond). 1996 Apr;46(2):146-50. doi: 10.1093/occmed/46.2.146. Occup Med (Lond). 1996. PMID: 8776252
-
[Influenza vaccination of nurses in an Italian pediatric hospital: effects on absenteeism and on costs, factors associated with vaccine uptake and analysis of personal motivations. A prospective cohort study].Assist Inferm Ric. 2007 Jan-Mar;26(1):5-13. Assist Inferm Ric. 2007. PMID: 17489334 Italian.
-
Influenza vaccination of school teachers: A scoping review and an impact estimation.PLoS One. 2022 Aug 11;17(8):e0272332. doi: 10.1371/journal.pone.0272332. eCollection 2022. PLoS One. 2022. PMID: 35951517 Free PMC article.
Cited by
-
Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant.Infect Immun. 1982 Oct;38(1):218-25. doi: 10.1128/iai.38.1.218-225.1982. Infect Immun. 1982. PMID: 6982860 Free PMC article.
-
Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.Drugs Aging. 2000 Sep;17(3):217-27. doi: 10.2165/00002512-200017030-00005. Drugs Aging. 2000. PMID: 11043820 Review.
-
Quantifying influenza vaccine efficacy and antigenic distance.Vaccine. 2006 May 1;24(18):3881-8. doi: 10.1016/j.vaccine.2006.01.010. Epub 2006 Jan 19. Vaccine. 2006. PMID: 16460844 Free PMC article.
-
Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.Drugs. 2002;62(7):1013-24. doi: 10.2165/00003495-200262070-00003. Drugs. 2002. PMID: 11985488 Review.
-
Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.Infect Immun. 1983 Jun;40(3):1044-51. doi: 10.1128/iai.40.3.1044-1051.1983. Infect Immun. 1983. PMID: 6852910 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical